Browse grants
Federal and state grant opportunities with plain-English eligibility summaries. We aggregate public records — always verify the details on the funder’s site before applying. Or browse the complete index →
Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
Due Nov 10, 2026National Institutes of Health · Amount varies
This NIH U01 grant funds research using expanded-access data for investigational drugs to help intermediate-size populations of ALS patients who are not eligible for ongoing clinical trials; a clinical trial is required. Eligibility is narrow: applicants must be clinical trial sites participating in a phase 2/3 or phase 3 trial sponsored by a small business that is the FDA-designated sponsor of the relevant drug. Foreign organizations and foreign components are not eligible. No award amounts are listed. This is a highly specialized opportunity tied to an existing small-business-sponsored ALS drug trial, not a general grant.
ResearchersSmall businessNarrow eligibilityNIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
Due Apr 5, 2027National Institutes of Health · Amount varies
This NIH STTR program (R41/R42) funds U.S. small businesses that partner with a nonprofit research institution to move scientific innovations toward commercialization. Eligibility is limited to U.S. small business concerns as defined by the SBA, and foreign organizations are not eligible. No award amount is listed.
Small businessNarrow eligibilityNIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
Due Apr 5, 2027National Institutes of Health · Amount varies
This NIH/CDC/FDA SBIR program (R43/R44) funds U.S. small businesses developing scientific innovations toward commercial products through feasibility and R&D studies. Eligibility is limited to U.S. small business concerns as defined by the SBA, and foreign organizations are not eligible. No award amount is listed.
Small businessNarrow eligibilityBioengineering Partnerships with Industry (U01 Clinical Trial Optional)
Due Sep 7, 2027National Institutes of Health · Amount varies
This NIH (U01) program funds academic-industry research partnerships that develop and advance bioengineering tools and technologies to address biomedical problems, aiming for solutions deployable within roughly 5-10 years. Eligible applicants are research organizations including universities, colleges, government and tribal entities, and faith- or community-based organizations; it is geared toward multidisciplinary research teams partnered with industry, not individuals or general nonprofits. Award amounts are not specified. Applicants should expect a collaborative, milestone-driven structure.
ResearchersSchools & universitiesSmall businessGovernment / tribal+1 moreDepartment of Defense HIV/AIDS Prevention Program
Due Sep 18, 2027Defense Health Agency Contracting Activity - DHACA · Amount varies
This Department of Defense (DHAPP/PEPFAR) program funds HIV/AIDS prevention, care, and treatment interventions delivered through the military health systems of foreign countries. Eligibility is described as unrestricted (open to any type of entity), subject to clarification in the announcement, but the work is inherently international and country-specific, so it suits organizations capable of working with foreign militaries. The announcement is revised regularly with country-specific narratives, and award amounts are not specified. Review the full announcement and its country attachments to confirm eligibility and scope.
NonprofitsSmall businessResearchersBroad eligibilityBlueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional)
Due Jan 28, 2028National Institutes of Health · Amount varies
This NIH program (Blueprint MedTech Translator) funds translational research and clinical feasibility studies for therapeutic and diagnostic devices targeting nervous- or neuromuscular-system disorders, open to a broad range of institutions including HBCUs, Hispanic-serving institutions, tribal colleges, faith- and community-based organizations, and individuals or businesses developing their own devices. It is a milestone-driven cooperative agreement requiring NIH staff involvement in project planning and monitoring. No award amount is specified, and the deadline is not imminent.
NonprofitsSmall businessResearchersSchools & universities+1 moreCommercial Fishing Occupational Safety Research Cooperative Agreement (U01)
Due Jan 31, 2028Centers for Disease Control and Prevention - ERA · $150K–$975K
Open to universities and researchers, nonprofits, businesses (including small businesses), and individuals with expertise in commercial fishing and maritime safety. Funds research to improve worker safety in commercial fishing — vessel design, survival and emergency equipment, monitoring and communication systems. Awards run roughly $150,000–$975,000, administered by CDC/NIOSH.
ResearchersNonprofitsSmall businessIndividuals+1 moreHEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)
Due Feb 20, 2029National Institutes of Health · Amount varies
This NIH HEAL Initiative UG3/UH3 cooperative agreement funds preclinical optimization and development of safe, non-addictive small-molecule and biologic therapeutics for treating pain, advancing candidates toward Phase II trials. Applicants must already have a promising lead candidate, a strong biological rationale, and established assays. Foreign organizations and foreign components of U.S. organizations are not eligible to apply.
ResearchersSmall businessSchools & universitiesNarrow eligibilityNIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional)
Due Apr 5, 2029National Institutes of Health · Amount varies
This NIH SBIR Phase IIB award is restricted to U.S. small business concerns that have previously received an NIH SBIR or STTR Phase II award; it bridges the gap between Phase II and commercialization for later-stage R&D. Only one such award is allowed per project, and applications must be submitted within the first six due dates after the Phase II budget period ends, so it is narrow and limited to existing grantees. Foreign organizations are not eligible to apply.
Small businessNarrow eligibilitySBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional)
Due Apr 5, 2029National Institutes of Health · Amount varies
This NIH SBIR/STTR Commercialization Readiness Pilot (CRP) is restricted to U.S. small business concerns (as defined by the SBA) and helps move NIH-funded SBIR/STTR projects from late-stage development toward commercialization. It supports later-stage R&D and technical assistance such as replication studies, IND/IDE-enabling work, clinical studies, manufacturing scale-up, and regulatory support, and a significant portion may be subcontracted. Foreign organizations are not eligible to apply.
Small businessNarrow eligibilityRFA-IP-18-000
Due Sep 30, 2030Centers for Disease Control and Prevention - ERA · Amount varies
This CDC health research opportunity (RFA-IP-18-000) is open to states, universities, counties, small businesses, and nonprofit organizations. The entry is a placeholder for Type 6 (continuation/competing renewal) applications and does not state award amounts or program specifics. Because it appears aimed at existing grantees, check with CDC about eligibility if you have not held a prior award.
NonprofitsSmall businessResearchersGovernment / tribal+2 moreRFA-OE-18-000
Due Sep 30, 2030Centers for Disease Control and Prevention - ERA · Amount varies
This CDC health research opportunity (RFA-OE-18-000) is open to states, universities, counties, small businesses, and nonprofit organizations. It is listed only as a placeholder for Type 6 (continuation/competing renewal) applications, with no award amounts or detailed requirements. Since it appears intended for existing grantees, confirm eligibility with CDC before applying as a new applicant.
NonprofitsSmall businessResearchersGovernment / tribal+2 moreRFA-DD-18-000
Due Sep 30, 2030Centers for Disease Control and Prevention - ERA · Amount varies
This CDC health research opportunity (RFA-DD-18-000) is open to states, universities, counties, small businesses, and nonprofit organizations. It is a placeholder listing for renewal-type applications and provides no award amounts or detailed program requirements. As it appears geared toward existing grantees, confirm eligibility with CDC before applying as a new applicant.
NonprofitsSmall businessResearchersGovernment / tribal+2 moreRFA-DP-18-000
Due Sep 30, 2030Centers for Disease Control and Prevention - ERA · Amount varies
This CDC health research opportunity (RFA-DP-18-000) is open to states, universities, counties, small businesses, and nonprofit organizations. The entry is a placeholder for Type 6 (continuation/competing renewal) applications and does not list award amounts or program details. As it appears geared toward existing grantees, check with CDC about eligibility before applying as a new organization.
NonprofitsSmall businessResearchersGovernment / tribal+2 moreRFA-EH-18-000
Due Sep 30, 2030Centers for Disease Control and Prevention - ERA · Amount varies
This CDC health research opportunity (RFA-EH-18-000) is open to states, universities, counties, small businesses, and nonprofit organizations. It is a placeholder for Type 6 (continuation/competing renewal) applications, with no stated award amounts or detailed requirements. Because it appears aimed at existing grantees, confirm eligibility with CDC if you are a first-time applicant.
NonprofitsSmall businessResearchersGovernment / tribal+2 moreRFA-TP-18-000
Due Sep 30, 2030Centers for Disease Control and Prevention - ERA · Amount varies
This CDC health research opportunity (RFA-TP-18-000) is open to states, universities, counties, small businesses, and nonprofit organizations. The entry is a placeholder for Type 6 (continuation/competing renewal) applications and does not list award amounts or program details. Since it appears intended for existing grantees, check with CDC about eligibility before applying as a new organization.
NonprofitsSmall businessResearchersGovernment / tribal+2 moreRFA-CD-18-000
Due Sep 30, 2030Centers for Disease Control and Prevention - ERA · Amount varies
This CDC health research opportunity (RFA-CD-18-000) is open to states, universities, counties, small businesses, and nonprofit organizations. It is a placeholder for Type 6 (continuation/competing renewal) applications, with no stated award amounts or specific requirements. Because it appears aimed at existing grantees, confirm eligibility with CDC if you are a first-time applicant.
NonprofitsSmall businessResearchersGovernment / tribal+2 moreRFA-CE-18-000
Due Sep 30, 2030Centers for Disease Control and Prevention - ERA · Amount varies
This is a CDC health research opportunity (RFA-CE-18-000) open to a broad range of applicants, including states, universities, counties, small businesses, and nonprofit organizations. It is described only as a placeholder for Type 6 (continuation/competing renewal) applications, so funding amounts and specific program details are not stated. Because it appears geared toward existing grantees submitting renewal-type applications, confirm with CDC whether new applicants are eligible before applying.
NonprofitsSmall businessResearchersGovernment / tribal+2 moreRFA-CC-18-000
Due Sep 30, 2030Centers for Disease Control and Prevention - ERA · Amount varies
This CDC health research opportunity (RFA-CC-18-000) is open to states, universities, counties, small businesses, and nonprofit organizations. The listing is a placeholder for Type 6 (continuation/competing renewal) applications and gives no award amounts or program details. As it appears geared toward existing grantees, verify with CDC whether new organizations can apply.
NonprofitsSmall businessResearchersGovernment / tribal+2 moreRFA-CK-18-000
Due Sep 30, 2030Centers for Disease Control and Prevention - ERA · Amount varies
This CDC health research opportunity (RFA-CK-18-000) is open to states, universities, counties, small businesses, and nonprofit organizations. It is listed only as a placeholder for Type 6 (continuation/competing renewal) applications, with no award amounts or specific requirements provided. Because it appears intended for existing grantees, confirm with CDC whether new applicants can apply.
NonprofitsSmall businessResearchersGovernment / tribal+2 more